Investors turn to drugs giants to steady jitters and sustain market rally

BRITISH stock market investors will turn to drugs and drinks companies this week, for evidence of whether British firms can repeat the earnings revival shown by US counterparts, seen as a key to sustaining the recent rally.

Europe's two biggest drugs firms, GlaxoSmithKline and AstraZeneca report third quarter results, and spirits firm, Allied Domecq reports full-year results.

Its bigger rival Diageo is set to update on trading.